Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

NCT07405424 | Recruiting

• 1 other identifier: IRB25-0210
• Study Type: interventional
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.

Conditions

Leukemia

Outcome Measures

Primary Outcomes (2)

• Is it feasible to enroll patients to a spiritual intervention study?

  Study will compare the number of potential participants to those that enroll and complete 3 out of 4 study intervention sessions.

  End of study (approximately 2 years)

• Will patients accept using the study specific spiritual intervention?

  This will be measured on using the Lothian Chaplaincy Patient Reported Outcome Measure (PROM) questionnaire. This measures patient feelings related to spiritual care using rating from not at all to all of the time.

  End of study (approximately 2 years)

Secondary Outcomes (3)

• Improvement on Patient Reported Spiritual Wellness

  End of study (approximately 2 years)

• Improvement on Patient Reported Quality of Life

  End of study (approximately 2 years)

• Improvement on Patient Reported Mood

  End of study (approximately 2 years)

Study Arms (2)

Spiritual Intervention Arm

EXPERIMENTAL

Participants receive a study specific spiritual care intervention.

Behavioral: SCORE Intervention

No Intervention Arm

NO INTERVENTION

Interventions

SCORE Intervention BEHAVIORAL

Participants assigned to this arm will receive regularly scheduled visits from the study spiritual care team during their hospital admission (four times within 14 days).

Spiritual Intervention Arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults (18 years or older)
• Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy
• Ability to read, understand, and speak the English language
• Ability to understand and the willingness to sign a written informed consent document

You may not qualify if:

• Unable to comply with spiritual care intervention
• Relapsed or refractory acute leukemia
• Cognitive deficits that limit participation and survey questionnaire completion

Sponsors & Collaborators

• University of Chicago: lead

Study Sites (1)

UChicago Medicine Comprehensive Cancer Center

Chicago, Illinois, 60637, United States

RECRUITING

MeSH Terms

Conditions

Leukemia

Condition Hierarchy (Ancestors)

Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Officials

• Wendy Stock

  University of Chicago

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Trials Intake

CONTACT

1-855-702-8222; cancerclinicaltrials@bsd.uchicago.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 15, 2025
• First Posted: February 12, 2026
• Study Start (Estimated): June 20, 2026
• Primary Completion (Estimated): June 16, 2028
• Study Completion (Estimated): June 16, 2028
• Last Updated: March 4, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)